Introduction: A potentially new marker of cardiovascular diseases—proadrenomedullin is the
precursor of adrenomedullin, which is a multifunctional peptide hormone, produced in most …

Objectives: Risk assessment in ICU patients using commonly used prognostic models may
be influenced using different data definitions and by errors in data collection. We …

Background and Objectives: the cardiovascular adverse events including mortality and heart
failure, persist significantly during the first months after the acute phase of ST-segment …

Objectives: This study sought to assess the prognostic impact of midregional pro-
adrenomedullin (MR-proADM) after an acute myocardial infarction (AMI). Background …

Objectives: Systemic inflammatory response leading to multiple organ dysfunctions (MODS)
is a major complication after cardiopulmonary bypass especially in patients with infective …

Background: There is evidence that adrenomedullin has autocrine or paracrine activities that
oppose cardiac remodelling. However, it remains unclear whether it exerts those local …

Background: Adrenomedullin (AM) is a potent vasodilator peptide. Plasma AM levels are
increased in heart diseases and in sepsis. Heart surgery under cardiopulmonary bypass …

AIMS: In ambulatory patients with coronary artery disease (CAD) we aimed to evaluate the
diagnostic performance of mid-regional pro-adrenomedullin (MR-proADM) for the detection …

Objective: We evaluated the utility of preoperative midregional (MR) pro-adrenomedullin
(proADM) and cardiac troponin T (TnT) for improved detection of patients at high risk for …

Background The assessment of acute heart failure (AHF) in patients with acute coronary
syndrome (ACS) is challenging. This study tested whether measuring plasma …